64157-93-3 Usage
Uses
Used in Pharmaceutical Industry:
[4-(4-[(2-chloroethyl)sulfanyl]butanoylamino)phenyl]phosphonic acid is used as a pharmaceutical compound for its potential reactivity and complexing properties. The presence of the chloroethyl group may allow for interactions with other molecules, while the phosphonic acid group could be utilized for chelating purposes. [4-(4-[(2-chloroethyl)sulfanyl]butanoylamino)phenyl]phosphonic acid may be further developed into drugs targeting specific diseases or conditions.
Used in Agrochemical Industry:
In the agrochemical industry, [4-(4-[(2-chloroethyl)sulfanyl]butanoylamino)phenyl]phosphonic acid is used as a building block for the development of new agrochemicals. Its unique structure, including the chloroethyl sulfanyl group, may provide novel properties and reactivity, contributing to the creation of more effective and targeted agrochemical products.
Used in Chemical Synthesis:
[4-(4-[(2-chloroethyl)sulfanyl]butanoylamino)phenyl]phosphonic acid is used as a synthetic building block for the creation of more complex molecules. Its structural components, such as the phenyl ring and phosphonic acid group, can be leveraged in chemical synthesis to produce a variety of compounds with diverse applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 64157-93-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,1,5 and 7 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 64157-93:
(7*6)+(6*4)+(5*1)+(4*5)+(3*7)+(2*9)+(1*3)=133
133 % 10 = 3
So 64157-93-3 is a valid CAS Registry Number.
64157-93-3Relevant academic research and scientific papers
Chemoimmunotherapy of cancer
Soloway,Wright,Subramanyam,Gozzo
, p. 1357 - 1362 (2007/10/05)
The preparation of a series of water-soluble mustard haptens for chemoimmunotherapy of cancer is described. Preliminary screening data are given, indicating some activity against P388 lymphocytkc leukemia for those compounds containing the most potent immunogenic functional groups.
